^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Mercy Halo™ Test

    Company:
    Mercy Bio
    Type:
    Laboratory Developed Test

    Details

    Evidence
    News
    The novel Mercy Halo technology enables simultaneous detection of multiple cancer-related biomarkers co-localized on the surface of individual tumor-derived extracellular vesicles, which are abundant in circulation and can be readily measured. The Mercy Halo OC assay is designed to detect stage I/II ovarian cancer and to distinguish cancer from benign conditions.
    Cancer:
    Ovarian Cancer, Ovarian Serous Adenocarcinoma
    Method:
    Liquid biopsy